Global Remdesivir (COVID-19) Sales Market Report 2021

Publisher Name :
Date: 27-Jul-2021
No. of pages: 132
Inquire Before Buying

The global Remdesivir (COVID-19) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Remdesivir (COVID-19) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- 5mg

- 10mg

- 50mg

- 100mg

Segment by Application

- Hospital

- Clinics

- Drug Store

- Others

The Remdesivir (COVID-19) market is analysed and market size information is provided by regions (countries). Segment by Application, the Remdesivir (COVID-19) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Gilead Sciences

- Bright Gene

- Hainan Haiyao

- Kelun Pharma

- Hunan Warrant Pharmaceutical

- Borui Bio-Pharmaceutical

- Berry Global Group

- Inovio Pharmaceuticals

Global Remdesivir (COVID-19) Sales Market Report 2021

Table of Contents
1 Remdesivir (COVID-19) Market Overview
1.1 Remdesivir (COVID-19) Product Scope
1.2 Remdesivir (COVID-19) Segment by Type
1.2.1 Global Remdesivir (COVID-19) Sales by Type (2016 & 2021 & 2027)
1.2.2 5mg
1.2.3 10mg
1.2.4 50mg
1.2.5 100mg
1.3 Remdesivir (COVID-19) Segment by Application
1.3.1 Global Remdesivir (COVID-19) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Drug Store
1.3.5 Others
1.4 Remdesivir (COVID-19) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Remdesivir (COVID-19) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Remdesivir (COVID-19) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Remdesivir (COVID-19) Price Trends (2016-2027)
2 Remdesivir (COVID-19) Estimates and Forecasts by Region
2.1 Global Remdesivir (COVID-19) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Remdesivir (COVID-19) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Remdesivir (COVID-19) Sales Market Share by Region (2016-2021)
2.2.2 Global Remdesivir (COVID-19) Revenue Market Share by Region (2016-2021)
2.3 Global Remdesivir (COVID-19) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Remdesivir (COVID-19) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Remdesivir (COVID-19) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Remdesivir (COVID-19) Estimates and Projections (2016-2027)
2.4.2 Europe Remdesivir (COVID-19) Estimates and Projections (2016-2027)
2.4.3 China Remdesivir (COVID-19) Estimates and Projections (2016-2027)
2.4.4 Japan Remdesivir (COVID-19) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Remdesivir (COVID-19) Estimates and Projections (2016-2027)
2.4.6 India Remdesivir (COVID-19) Estimates and Projections (2016-2027)
3 Global Remdesivir (COVID-19) Competition Landscape by Players
3.1 Global Top Remdesivir (COVID-19) Players by Sales (2016-2021)
3.2 Global Top Remdesivir (COVID-19) Players by Revenue (2016-2021)
3.3 Global Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Remdesivir (COVID-19) as of 2020)
3.4 Global Remdesivir (COVID-19) Average Price by Company (2016-2021)
3.5 Manufacturers Remdesivir (COVID-19) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Remdesivir (COVID-19) Market Size by Type
4.1 Global Remdesivir (COVID-19) Historic Market Review by Type (2016-2021)
4.1.1 Global Remdesivir (COVID-19) Sales Market Share by Type (2016-2021)
4.1.2 Global Remdesivir (COVID-19) Revenue Market Share by Type (2016-2021)
4.1.3 Global Remdesivir (COVID-19) Price by Type (2016-2021)
4.2 Global Remdesivir (COVID-19) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Remdesivir (COVID-19) Sales Forecast by Type (2022-2027)
4.2.2 Global Remdesivir (COVID-19) Revenue Forecast by Type (2022-2027)
4.2.3 Global Remdesivir (COVID-19) Price Forecast by Type (2022-2027)
5 Global Remdesivir (COVID-19) Market Size by Application
5.1 Global Remdesivir (COVID-19) Historic Market Review by Application (2016-2021)
5.1.1 Global Remdesivir (COVID-19) Sales Market Share by Application (2016-2021)
5.1.2 Global Remdesivir (COVID-19) Revenue Market Share by Application (2016-2021)
5.1.3 Global Remdesivir (COVID-19) Price by Application (2016-2021)
5.2 Global Remdesivir (COVID-19) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Remdesivir (COVID-19) Sales Forecast by Application (2022-2027)
5.2.2 Global Remdesivir (COVID-19) Revenue Forecast by Application (2022-2027)
5.2.3 Global Remdesivir (COVID-19) Price Forecast by Application (2022-2027)
6 North America Remdesivir (COVID-19) Market Facts & Figures
6.1 North America Remdesivir (COVID-19) Sales by Company
6.1.1 North America Remdesivir (COVID-19) Sales by Company (2016-2021)
6.1.2 North America Remdesivir (COVID-19) Revenue by Company (2016-2021)
6.2 North America Remdesivir (COVID-19) Sales Breakdown by Type
6.2.1 North America Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021)
6.2.2 North America Remdesivir (COVID-19) Sales Breakdown by Type (2022-2027)
6.3 North America Remdesivir (COVID-19) Sales Breakdown by Application
6.3.1 North America Remdesivir (COVID-19) Sales Breakdown by Application (2016-2021)
6.3.2 North America Remdesivir (COVID-19) Sales Breakdown by Application (2022-2027)
7 Europe Remdesivir (COVID-19) Market Facts & Figures
7.1 Europe Remdesivir (COVID-19) Sales by Company
7.1.1 Europe Remdesivir (COVID-19) Sales by Company (2016-2021)
7.1.2 Europe Remdesivir (COVID-19) Revenue by Company (2016-2021)
7.2 Europe Remdesivir (COVID-19) Sales Breakdown by Type
7.2.1 Europe Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Remdesivir (COVID-19) Sales Breakdown by Type (2022-2027)
7.3 Europe Remdesivir (COVID-19) Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)
8 China Remdesivir (COVID-19) Market Facts & Figures
8.1 China Remdesivir (COVID-19) Sales by Company
8.1.1 China Remdesivir (COVID-19) Sales by Company (2016-2021)
8.1.2 China Remdesivir (COVID-19) Revenue by Company (2016-2021)
8.2 China Remdesivir (COVID-19) Sales Breakdown by Type
8.2.1 China Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021)
8.2.2 China Remdesivir (COVID-19) Sales Breakdown by Type (2022-2027)
8.3 China Remdesivir (COVID-19) Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Remdesivir (COVID-19) Market Facts & Figures
9.1 Japan Remdesivir (COVID-19) Sales by Company
9.1.1 Japan Remdesivir (COVID-19) Sales by Company (2016-2021)
9.1.2 Japan Remdesivir (COVID-19) Revenue by Company (2016-2021)
9.2 Japan Remdesivir (COVID-19) Sales Breakdown by Type
9.2.1 Japan Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Remdesivir (COVID-19) Sales Breakdown by Type (2022-2027)
9.3 Japan Remdesivir (COVID-19) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Remdesivir (COVID-19) Market Facts & Figures
10.1 Southeast Asia Remdesivir (COVID-19) Sales by Company
10.1.1 Southeast Asia Remdesivir (COVID-19) Sales by Company (2016-2021)
10.1.2 Southeast Asia Remdesivir (COVID-19) Revenue by Company (2016-2021)
10.2 Southeast Asia Remdesivir (COVID-19) Sales Breakdown by Type
10.2.1 Southeast Asia Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Remdesivir (COVID-19) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Remdesivir (COVID-19) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Remdesivir (COVID-19) Market Facts & Figures
11.1 India Remdesivir (COVID-19) Sales by Company
11.1.1 India Remdesivir (COVID-19) Sales by Company (2016-2021)
11.1.2 India Remdesivir (COVID-19) Revenue by Company (2016-2021)
11.2 India Remdesivir (COVID-19) Sales Breakdown by Type
11.2.1 India Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021)
11.2.2 India Remdesivir (COVID-19) Sales Breakdown by Type (2022-2027)
11.3 India Remdesivir (COVID-19) Sales Breakdown by Application
11.3.1 India Remdesivir (COVID-19) Sales Breakdown by Application (2016-2021)
11.3.2 India Remdesivir (COVID-19) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Remdesivir (COVID-19) Business
12.1 Gilead Sciences
12.1.1 Gilead Sciences Corporation Information
12.1.2 Gilead Sciences Business Overview
12.1.3 Gilead Sciences Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Sciences Remdesivir (COVID-19) Products Offered
12.1.5 Gilead Sciences Recent Development
12.2 Bright Gene
12.2.1 Bright Gene Corporation Information
12.2.2 Bright Gene Business Overview
12.2.3 Bright Gene Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bright Gene Remdesivir (COVID-19) Products Offered
12.2.5 Bright Gene Recent Development
12.3 Hainan Haiyao
12.3.1 Hainan Haiyao Corporation Information
12.3.2 Hainan Haiyao Business Overview
12.3.3 Hainan Haiyao Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Hainan Haiyao Remdesivir (COVID-19) Products Offered
12.3.5 Hainan Haiyao Recent Development
12.4 Kelun Pharma
12.4.1 Kelun Pharma Corporation Information
12.4.2 Kelun Pharma Business Overview
12.4.3 Kelun Pharma Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Kelun Pharma Remdesivir (COVID-19) Products Offered
12.4.5 Kelun Pharma Recent Development
12.5 Hunan Warrant Pharmaceutical
12.5.1 Hunan Warrant Pharmaceutical Corporation Information
12.5.2 Hunan Warrant Pharmaceutical Business Overview
12.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Products Offered
12.5.5 Hunan Warrant Pharmaceutical Recent Development
12.6 Borui Bio-Pharmaceutical
12.6.1 Borui Bio-Pharmaceutical Corporation Information
12.6.2 Borui Bio-Pharmaceutical Business Overview
12.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Products Offered
12.6.5 Borui Bio-Pharmaceutical Recent Development
12.7 Berry Global Group
12.7.1 Berry Global Group Corporation Information
12.7.2 Berry Global Group Business Overview
12.7.3 Berry Global Group Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Berry Global Group Remdesivir (COVID-19) Products Offered
12.7.5 Berry Global Group Recent Development
12.8 Inovio Pharmaceuticals
12.8.1 Inovio Pharmaceuticals Corporation Information
12.8.2 Inovio Pharmaceuticals Business Overview
12.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Inovio Pharmaceuticals Remdesivir (COVID-19) Products Offered
12.8.5 Inovio Pharmaceuticals Recent Development
13 Remdesivir (COVID-19) Manufacturing Cost Analysis
13.1 Remdesivir (COVID-19) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Remdesivir (COVID-19)
13.4 Remdesivir (COVID-19) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Remdesivir (COVID-19) Distributors List
14.3 Remdesivir (COVID-19) Customers
15 Market Dynamics
15.1 Remdesivir (COVID-19) Market Trends
15.2 Remdesivir (COVID-19) Drivers
15.3 Remdesivir (COVID-19) Market Challenges
15.4 Remdesivir (COVID-19) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Remdesivir (COVID-19) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Remdesivir (COVID-19) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Remdesivir (COVID-19) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Remdesivir (COVID-19) Sales (K Units) by Region (2016-2021)
Table 5. Global Remdesivir (COVID-19) Sales Market Share by Region (2016-2021)
Table 6. Global Remdesivir (COVID-19) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Remdesivir (COVID-19) Revenue Share by Region (2016-2021)
Table 8. Global Remdesivir (COVID-19) Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Remdesivir (COVID-19) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Remdesivir (COVID-19) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Remdesivir (COVID-19) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Remdesivir (COVID-19) Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Remdesivir (COVID-19) Sales Share by Company (2016-2021)
Table 14. Global Remdesivir (COVID-19) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Remdesivir (COVID-19) Revenue Share by Company (2016-2021)
Table 16. Global Remdesivir (COVID-19) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Remdesivir (COVID-19) as of 2020)
Table 17. Global Remdesivir (COVID-19) Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Remdesivir (COVID-19) Manufacturing Sites and Area Served
Table 19. Manufacturers Remdesivir (COVID-19) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Remdesivir (COVID-19) Sales (K Units) by Type (2016-2021)
Table 22. Global Remdesivir (COVID-19) Sales Share by Type (2016-2021)
Table 23. Global Remdesivir (COVID-19) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Remdesivir (COVID-19) Price (US$/Unit) by Type (2016-2021)
Table 25. Global Remdesivir (COVID-19) Sales Share by Type (2022-2027)
Table 26. Global Remdesivir (COVID-19) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Remdesivir (COVID-19) Revenue Share by Type (2022-2027)
Table 28. Global Remdesivir (COVID-19) Price (US$/Unit) by Type (2022-2027)
Table 29. Global Remdesivir (COVID-19) Sales (K Units) by Application (2016-2021)
Table 30. Global Remdesivir (COVID-19) Sales Share by Application (2016-2021)
Table 31. Global Remdesivir (COVID-19) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Remdesivir (COVID-19) Price (US$/Unit) by Application (2016-2021)
Table 33. Global Remdesivir (COVID-19) Sales (K Units) by Application (2022-2027)
Table 34. Global Remdesivir (COVID-19) Sales Share by Application (2022-2027)
Table 35. Global Remdesivir (COVID-19) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Remdesivir (COVID-19) Revenue Share by Application (2022-2027)
Table 37. Global Remdesivir (COVID-19) Price (US$/Unit) by Application (2022-2027)
Table 38. North America Remdesivir (COVID-19) Sales (K Units) by Company (2016-2021)
Table 39. North America Remdesivir (COVID-19) Sales Market Share by Company (2016-2021)
Table 40. North America Remdesivir (COVID-19) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Remdesivir (COVID-19) Revenue Market Share by Company (2016-2021)
Table 42. North America Remdesivir (COVID-19) Sales by Type (2016-2021) & (K Units)
Table 43. North America Remdesivir (COVID-19) Sales Market Share by Type (2016-2021)
Table 44. North America Remdesivir (COVID-19) Sales by Type (2022-2027) & (K Units)
Table 45. North America Remdesivir (COVID-19) Sales Market Share by Type (2022-2027)
Table 46. North America Remdesivir (COVID-19) Sales by Application (2016-2021) & (K Units)
Table 47. North America Remdesivir (COVID-19) Sales Market Share by Application (2016-2021)
Table 48. North America Remdesivir (COVID-19) Sales by Application (2022-2027) & (K Units)
Table 49. North America Remdesivir (COVID-19) Sales Market Share by Application (2022-2027)
Table 50. Europe Remdesivir (COVID-19) Sales (K Units) by Company (2016-2021)
Table 51. Europe Remdesivir (COVID-19) Sales Market Share by Company (2016-2021)
Table 52. Europe Remdesivir (COVID-19) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Remdesivir (COVID-19) Revenue Market Share by Company (2016-2021)
Table 54. Europe Remdesivir (COVID-19) Sales by Type (2016-2021) & (K Units)
Table 55. Europe Remdesivir (COVID-19) Sales Market Share by Type (2016-2021)
Table 56. Europe Remdesivir (COVID-19) Sales by Type (2022-2027) & (K Units)
Table 57. Europe Remdesivir (COVID-19) Sales Market Share by Type (2022-2027)
Table 58. Europe Remdesivir (COVID-19) Sales by Application (2016-2021) & (K Units)
Table 59. Europe Remdesivir (COVID-19) Sales Market Share by Application (2016-2021)
Table 60. Europe Remdesivir (COVID-19) Sales by Application (2022-2027) & (K Units)
Table 61. Europe Remdesivir (COVID-19) Sales Market Share by Application (2022-2027)
Table 62. China Remdesivir (COVID-19) Sales (K Units) by Company (2016-2021)
Table 63. China Remdesivir (COVID-19) Sales Market Share by Company (2016-2021)
Table 64. China Remdesivir (COVID-19) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Remdesivir (COVID-19) Revenue Market Share by Company (2016-2021)
Table 66. China Remdesivir (COVID-19) Sales by Type (2016-2021) & (K Units)
Table 67. China Remdesivir (COVID-19) Sales Market Share by Type (2016-2021)
Table 68. China Remdesivir (COVID-19) Sales by Type (2022-2027) & (K Units)
Table 69. China Remdesivir (COVID-19) Sales Market Share by Type (2022-2027)
Table 70. China Remdesivir (COVID-19) Sales by Application (2016-2021) & (K Units)
Table 71. China Remdesivir (COVID-19) Sales Market Share by Application (2016-2021)
Table 72. China Remdesivir (COVID-19) Sales by Application (2022-2027) & (K Units)
Table 73. China Remdesivir (COVID-19) Sales Market Share by Application (2022-2027)
Table 74. Japan Remdesivir (COVID-19) Sales (K Units) by Company (2016-2021)
Table 75. Japan Remdesivir (COVID-19) Sales Market Share by Company (2016-2021)
Table 76. Japan Remdesivir (COVID-19) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Remdesivir (COVID-19) Revenue Market Share by Company (2016-2021)
Table 78. Japan Remdesivir (COVID-19) Sales by Type (2016-2021) & (K Units)
Table 79. Japan Remdesivir (COVID-19) Sales Market Share by Type (2016-2021)
Table 80. Japan Remdesivir (COVID-19) Sales by Type (2022-2027) & (K Units)
Table 81. Japan Remdesivir (COVID-19) Sales Market Share by Type (2022-2027)
Table 82. Japan Remdesivir (COVID-19) Sales by Application (2016-2021) & (K Units)
Table 83. Japan Remdesivir (COVID-19) Sales Market Share by Application (2016-2021)
Table 84. Japan Remdesivir (COVID-19) Sales by Application (2022-2027) & (K Units)
Table 85. Japan Remdesivir (COVID-19) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Remdesivir (COVID-19) Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Remdesivir (COVID-19) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Remdesivir (COVID-19) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Remdesivir (COVID-19) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Remdesivir (COVID-19) Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Remdesivir (COVID-19) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Remdesivir (COVID-19) Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Remdesivir (COVID-19) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Remdesivir (COVID-19) Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Remdesivir (COVID-19) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Remdesivir (COVID-19) Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Remdesivir (COVID-19) Sales Market Share by Application (2022-2027)
Table 98. India Remdesivir (COVID-19) Sales (K Units) by Company (2016-2021)
Table 99. India Remdesivir (COVID-19) Sales Market Share by Company (2016-2021)
Table 100. India Remdesivir (COVID-19) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Remdesivir (COVID-19) Revenue Market Share by Company (2016-2021)
Table 102. India Remdesivir (COVID-19) Sales by Type (2016-2021) & (K Units)
Table 103. India Remdesivir (COVID-19) Sales Market Share by Type (2016-2021)
Table 104. India Remdesivir (COVID-19) Sales by Type (2022-2027) & (K Units)
Table 105. India Remdesivir (COVID-19) Sales Market Share by Type (2022-2027)
Table 106. India Remdesivir (COVID-19) Sales by Application (2016-2021) & (K Units)
Table 107. India Remdesivir (COVID-19) Sales Market Share by Application (2016-2021)
Table 108. India Remdesivir (COVID-19) Sales by Application (2022-2027) & (K Units)
Table 109. India Remdesivir (COVID-19) Sales Market Share by Application (2022-2027)
Table 110. Gilead Sciences Corporation Information
Table 111. Gilead Sciences Description and Business Overview
Table 112. Gilead Sciences Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Gilead Sciences Remdesivir (COVID-19) Product
Table 114. Gilead Sciences Recent Development
Table 115. Bright Gene Corporation Information
Table 116. Bright Gene Description and Business Overview
Table 117. Bright Gene Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Bright Gene Remdesivir (COVID-19) Product
Table 119. Bright Gene Recent Development
Table 120. Hainan Haiyao Corporation Information
Table 121. Hainan Haiyao Description and Business Overview
Table 122. Hainan Haiyao Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Hainan Haiyao Remdesivir (COVID-19) Product
Table 124. Hainan Haiyao Recent Development
Table 125. Kelun Pharma Corporation Information
Table 126. Kelun Pharma Description and Business Overview
Table 127. Kelun Pharma Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Kelun Pharma Remdesivir (COVID-19) Product
Table 129. Kelun Pharma Recent Development
Table 130. Hunan Warrant Pharmaceutical Corporation Information
Table 131. Hunan Warrant Pharmaceutical Description and Business Overview
Table 132. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product
Table 134. Hunan Warrant Pharmaceutical Recent Development
Table 135. Borui Bio-Pharmaceutical Corporation Information
Table 136. Borui Bio-Pharmaceutical Description and Business Overview
Table 137. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product
Table 139. Borui Bio-Pharmaceutical Recent Development
Table 140. Berry Global Group Corporation Information
Table 141. Berry Global Group Description and Business Overview
Table 142. Berry Global Group Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Berry Global Group Remdesivir (COVID-19) Product
Table 144. Berry Global Group Recent Development
Table 145. Inovio Pharmaceuticals Corporation Information
Table 146. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Inovio Pharmaceuticals Description and Business Overview
Table 148. Inovio Pharmaceuticals Remdesivir (COVID-19) Product
Table 149. Inovio Pharmaceuticals Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Remdesivir (COVID-19) Distributors List
Table 153. Remdesivir (COVID-19) Customers List
Table 154. Remdesivir (COVID-19) Market Trends
Table 155. Remdesivir (COVID-19) Market Drivers
Table 156. Remdesivir (COVID-19) Market Challenges
Table 157. Remdesivir (COVID-19) Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Remdesivir (COVID-19) Product Picture
Figure 2. Global Remdesivir (COVID-19) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Remdesivir (COVID-19) Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Clinics Examples
Figure 8. Drug Store Examples
Figure 9. Others Examples
Figure 10. Global Remdesivir (COVID-19) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Remdesivir (COVID-19) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Remdesivir (COVID-19) Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Remdesivir (COVID-19) Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 14. Global Remdesivir (COVID-19) Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Remdesivir (COVID-19) Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Remdesivir (COVID-19) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Remdesivir (COVID-19) Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Remdesivir (COVID-19) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Remdesivir (COVID-19) Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Remdesivir (COVID-19) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Remdesivir (COVID-19) Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Remdesivir (COVID-19) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Remdesivir (COVID-19) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Remdesivir (COVID-19) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Remdesivir (COVID-19) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Remdesivir (COVID-19) Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Remdesivir (COVID-19) Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Remdesivir (COVID-19) Players Market Share by Revenue in Remdesivir (COVID-19): 2016 & 2020
Figure 29. Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Remdesivir (COVID-19) Revenue Share by Type (2016-2021)
Figure 31. Global Remdesivir (COVID-19) Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Remdesivir (COVID-19) Revenue Share by Application (2016-2021)
Figure 33. Global Remdesivir (COVID-19) Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Remdesivir (COVID-19) Sales Market Share by Type in 2020
Figure 35. North America Remdesivir (COVID-19) Sales Market Share by Application in 2020
Figure 36. Europe Remdesivir (COVID-19) Sales Market Share by Type in 2020
Figure 37. Europe Remdesivir (COVID-19) Sales Market Share by Application in 2020
Figure 38. China Remdesivir (COVID-19) Sales Market Share by Type in 2020
Figure 39. China Remdesivir (COVID-19) Sales Market Share by Application in 2020
Figure 40. Japan Remdesivir (COVID-19) Sales Market Share by Type in 2020
Figure 41. Japan Remdesivir (COVID-19) Sales Market Share by Application in 2020
Figure 42. Southeast Asia Remdesivir (COVID-19) Sales Market Share by Type in 2020
Figure 43. Southeast Asia Remdesivir (COVID-19) Sales Market Share by Application in 2020
Figure 44. India Remdesivir (COVID-19) Sales Market Share by Type in 2020
Figure 45. India Remdesivir (COVID-19) Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Remdesivir (COVID-19)
Figure 48. Manufacturing Process Analysis of Remdesivir (COVID-19)
Figure 49. Remdesivir (COVID-19) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
  • 2021-2027 Global and Regional Alopecia Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 150
    The global Alopecia market was valued at 8658.89 Million USD in 2020 and will grow with a CAGR of 3.57% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South......
  • 2021-2027 Global and Regional Digital Radiography Detectors Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 156
    The global Digital Radiography Detectors market was valued at 165.45 Million USD in 2020 and will grow with a CAGR of 6.03% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East......
  • 2021-2027 Global and Regional Normal Saline for Parenteral Use Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 156
    The global Normal Saline for Parenteral Use market was valued at 2943.73 Million USD in 2020 and will grow with a CAGR of 3.1% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, E......
  • 2021-2027 Global and Regional Erectile Dysfunction Devices Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 153
    The global Erectile Dysfunction Devices market was valued at 1358.28 Million USD in 2020 and will grow with a CAGR of 5.49% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East......
  • 2021-2027 Global and Regional Portable Medical Electronics Products Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 149
    The global Portable Medical Electronics Products market was valued at 1043.45 Million USD in 2020 and will grow with a CAGR of 2.45% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North Amer......
  • 2021-2027 Global and Regional Healthcare Hernia Repair Devices Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 142
    The global Healthcare Hernia Repair Devices market was valued at 3877.54 Million USD in 2020 and will grow with a CAGR of 3.55% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, ......
  • 2021-2027 Global and Regional Disposable Ostomy Bags Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 161
    The global Disposable Ostomy Bags market was valued at 2428.09 Million USD in 2020 and will grow with a CAGR of 5.59% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia,......
  • 2021-2027 Global and Regional Analog X-ray Systems Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 168
    The global Analog X-ray Systems market was valued at 3033.69 Million USD in 2020 and will grow with a CAGR of 1.45% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, E......
  • 2021-2027 Global and Regional Mobile C-arm X-ray Tubes Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 152
    The global Mobile C-arm X-ray Tubes market was valued at 192.53 Million USD in 2020 and will grow with a CAGR of 4.34% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs